Dow Up0.15% Nasdaq Up0.21%

More On ACL.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Alchemia Limited (ACL.AX)

-ASX
0.61 0.00(0.00%) 2:10AM EDT
ProfileGet Profile for:
Alchemia Limited
3 Hi
Eight Mile Plains
Brisbane, QLD 4113
Australia - Map
Phone: 61 7 3340 0200
Fax: 61 7 3340 0222
Website: http://www.alchemia.com.au

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:29

Business Summary 

Alchemia Limited, a biotechnology company, develops human therapeutic products based on its proprietary drug discovery, drug targeting, and synthesis technologies in Australia and the United States. Its technologies include HyACT, a platform technology that uses the non-toxic and naturally occurring carbohydrate, hyaluronic acid as a drug delivery vehicle for a range of approved anti-cancer therapeutics; and Versatile Assembly on Stable Templates technology, a small molecule drug discovery technology. The company also provides generic fondaparinux, an anticoagulant drug for the prevention and treatment of deep vein thrombosis and pulmonary embolism. In addition, it develops HA-Irinotecan that is in Phase III clinical trials for the treatment of metastatic colorectal cancer, as well as in the phase II investigator-sponsored trials that focuses on small cell lung cancer. The company has collaboration agreements with AstraZeneca AB to discover and develop novel small molecules against multiple targets; Merck Serono to develop HA-Irinotecan in combination with therapeutic antibody, Erbitux (cetuximab), for patients with metastatic colorectal cancer; and IMBcom Asset Management Company for conducting research based upon certain voltage gated ion channel biological targets and library compounds, as well as with University of Queensland for ion channel drug discovery. Alchemia Limited also has research agreement with Monash University; and Cancer Research Technology Limited. The company was founded in 1995 and is headquartered in Brisbane, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Alchemia Limited

Key Executives 
 PayExercised
Mr. Thomas Liquard ,
Chief Exec. Officer
228.00KN/A
Dr. Tracie Ramsdale Ph.D., 51
Co-Founder, Chairman of Scientific Advisory Board, Non-Exec. Director, Chairman of Remuneration Committee, Member of Nomination Committee, Member of Audit & Risk Committee and Member of Due Diligence Committee
N/AN/A
Dr. Tracey Jean Brown B.Sc., Ph.D., 51
Chief Scientific Officer and VP of Oncology
N/AN/A
Dr. Goslik Schepers Ph.D.,
VP of Bus. Devel.
N/AN/A
Mr. Imran Ahamed CPA, ACMA, CGMA ,
Group Financial Controller
N/AN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.